Monoclonal Antibody to Prevent RSV in Infants Shows Positives Results in Phase 2b/3 Study
MK-1654 (clesrovimab) met its primary efficacy endpoint of incidence of patients with RSV-associated medically attended lower respiratory infections (MALRI) through Day 150.
Good Neighbor Pharmacy Customers Across the US Reflect and Look Forward
Good Neighbor Pharmacy customers from rural, suburban, and city areas reflect on the past year and discuss the future of independent pharmacy.
Long COVID Risk Reduced by 70% Following Vaccination
“If people think COVID is no big deal and decide to forgo vaccinations, they’re essentially doubling their risk of developing long COVID,” wrote investigators.
COVID-19 Cases Rise as Omicron-Derived FLiRT, LB.1 Variants Take Hold
Updated vaccines are expected to be available in the coming months.
15-Minute Saliva Test Aims to Close Tetanus Vaccination Gap
Global coverage for diphtheria, tetanus, and pertussis has reached its lowest point in 15 years.
Phase 1/2 Trial of Investigational Herpes Zoster Vaccine Candidate Underway
Researchers are evaluating the safety, tolerability, and immunogenicity of shingles vaccine candidate Z-1018.
